Metafuni, Elisabetta
 Distribuzione geografica
Continente #
EU - Europa 1.582
NA - Nord America 1.531
AS - Asia 311
AF - Africa 23
SA - Sud America 5
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.455
Nazione #
US - Stati Uniti d'America 1.519
DE - Germania 437
SE - Svezia 389
IT - Italia 297
CN - Cina 197
IE - Irlanda 114
FR - Francia 103
GB - Regno Unito 71
UA - Ucraina 71
FI - Finlandia 42
IN - India 34
SG - Singapore 31
CI - Costa d'Avorio 21
TR - Turchia 15
BE - Belgio 12
CA - Canada 12
HK - Hong Kong 12
RU - Federazione Russa 8
ES - Italia 6
TH - Thailandia 6
CZ - Repubblica Ceca 5
KR - Corea 5
AT - Austria 4
NL - Olanda 4
RO - Romania 3
AU - Australia 2
BR - Brasile 2
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
IR - Iran 2
LI - Liechtenstein 2
NO - Norvegia 2
PT - Portogallo 2
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
QA - Qatar 1
RS - Serbia 1
VN - Vietnam 1
Totale 3.455
Città #
Chandler 402
Ashburn 132
Dublin 112
San Mateo 68
Jacksonville 62
Rome 60
Houston 49
Nanjing 49
Dearborn 48
Florence 46
New York 45
Ann Arbor 42
Beijing 42
Marseille 42
Milan 41
Wilmington 36
Princeton 33
Lancaster 32
Cattolica 30
Nürnberg 29
Boston 27
Bremen 26
Nanchang 22
Abidjan 21
Helsinki 18
Los Angeles 18
Seattle 17
Chicago 15
Izmir 14
Singapore 14
Woodbridge 14
Fairfield 13
Lawrence 13
Brussels 12
Pune 12
Tianjin 12
Norwalk 11
Guangzhou 10
Hong Kong 10
London 10
Redwood City 10
Washington 10
Augusta 9
Hefei 9
Boardman 8
Lappeenranta 8
Mountain View 8
Munich 8
Toronto 8
Arezzo 7
Redmond 7
Shenyang 7
Leawood 6
Shanghai 6
Auburn Hills 5
Edinburgh 5
Kunming 5
Seoul 5
Zhengzhou 5
Changsha 4
Falls Church 4
Fremont 4
Nuremberg 4
San Francisco 4
Bangkok 3
Bologna 3
Brno 3
Columbus 3
Garden City 3
Hangzhou 3
Hebei 3
Naples 3
Philadelphia 3
Selargius 3
University Park 3
Amsterdam 2
Bagnacavallo 2
Bagnoli Irpino 2
Bang Bai Mai 2
Berlin 2
Cambridge 2
Essen 2
Ferrara 2
Fuzhou 2
Jiaxing 2
Jinan 2
Kemerovo 2
Lanzhou 2
Michigan City 2
Novara 2
Piacenza 2
Putian 2
Rocca d'Arazzo 2
Rovato 2
Settimo Milanese 2
Siziano 2
St Petersburg 2
Stockholm 2
Vaduz 2
Vigo 2
Totale 1.948
Nome #
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 159
Correlation between paraproteinaemia and viral reactivation after allo-SCT 132
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 130
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 128
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 121
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 119
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 107
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 93
Hyperleukocytosis and leukostasis: management of a medical emergency 93
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 91
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 91
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 88
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 83
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 79
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 75
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 72
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 70
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 66
Changes in protein serum levels during stem cell transplantation 64
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 63
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 63
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 62
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 60
Unrelated cord blood transplantation and post-transplant cyclophosphamide 59
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 59
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 58
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 58
Unrelated cord blood transplantation and post-transplant cyclophosphamide 57
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 57
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 56
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 55
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 52
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 52
ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- And Long-term Outcomes 52
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 48
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study 44
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 42
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 42
Second haploidentical stem cell transplantation for primary graft failure 40
Reducing infectious complications after allogeneic stem cell transplant 39
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 38
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 38
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 34
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 34
Extending long term follow up of patient with acute myeloid leukemia after autologous stem cell transplantation: Disclosing late mortality and causes of death 33
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 30
A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer 26
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 25
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 22
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 22
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 21
Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants 20
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 19
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 19
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 18
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 16
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation 16
A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer 16
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience 15
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant 13
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization? 13
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 13
Four cases of transfusion-transmitted Hepatitis E virus infection: Is it time to introduce donor screening in Italy? 11
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 10
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 y with Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study 9
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 8
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 8
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 7
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 7
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 6
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 6
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 4
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey 4
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 4
Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients 4
Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center 4
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 3
Late HBV reactivation after hematopoietic stem cell transplantation, despite long-term prophylaxis 2
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 2
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 1
Totale 3.580
Categoria #
all - tutte 15.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201957 0 0 0 0 0 0 0 0 0 0 39 18
2019/2020429 77 36 25 24 44 50 36 15 26 36 35 25
2020/2021237 9 19 10 15 20 17 15 12 31 10 72 7
2021/2022488 34 14 29 24 43 12 9 72 19 45 98 89
2022/20231.216 188 159 72 185 85 135 88 84 102 51 54 13
2023/2024631 29 156 45 60 21 94 65 43 17 56 45 0
Totale 3.580